BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 829163 CC1(C)CC(O)=C(C(=S)Nc2ccccc2)C(=O)N1 InChI=1S/C14H16N2O2S/c1-14(2)8-10(17)11(12(18)16-14)13(19)15-9-6-4-3-5-7-9/h3-7,17H,8H2,1-2H3,(H,15,19)(H,16,18) GYGGFEHHGMQBBO-UHFFFAOYSA-N 415401 Intermediate 1-1-1 (4-hydroxy-6,6-dimethyl-2-oxo-N-phenyl-1,2,5,6-tetrahydropyridine-3-carbothioamide)::US10428063, Example 1 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 11.6 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415401&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 137046321 433915438 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829164 O=C1NCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccncc1 InChI=1S/C18H16N4O/c23-18-15-14(8-11-20-18)22-16(12-6-9-19-10-7-12)17(15)21-13-4-2-1-3-5-13/h1-7,9-10,21-22H,8,11H2,(H,20,23) MTBRQOGPXZHFAH-UHFFFAOYSA-N 415402 Intermediate 1-1-2::US10428063, Example 2 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 7.89 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415402 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415402&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442134 433915439 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829165 Cc1cnccc1CNC1=C(C(=S)Nc2ccccc2)C(=O)NCC1 InChI=1S/C19H20N4OS/c1-13-11-20-9-7-14(13)12-22-16-8-10-21-18(24)17(16)19(25)23-15-5-3-2-4-6-15/h2-7,9,11,22H,8,10,12H2,1H3,(H,21,24)(H,23,25) KQOVARQHMQMHEH-UHFFFAOYSA-N 415403 Intermediate 1-2-3::US10428063, Example 3 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 244 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415403 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415403&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122453025 433915440 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829166 CCn1c2CC(C)(C)NC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C22H24N4O/c1-4-26-17-14-22(2,3)25-21(27)18(17)19(24-16-8-6-5-7-9-16)20(26)15-10-12-23-13-11-15/h5-13,24H,4,14H2,1-3H3,(H,25,27) HBRUJYPCDDDJIW-UHFFFAOYSA-N 415404 Example 4 (1-ethyl-6,6-dimethyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one)::US10428063, Example 4 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 14.6 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415404&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442095 433915441 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829167 CCC1C2=C(C(Nc3ccccc3)=C1c1ccncc1)C(=O)NCC2 InChI=1S/C21H21N3O/c1-2-16-17-10-13-23-21(25)19(17)20(24-15-6-4-3-5-7-15)18(16)14-8-11-22-12-9-14/h3-9,11-12,16,24H,2,10,13H2,1H3,(H,23,25) VQOCGXSGCQNFLY-UHFFFAOYSA-N 415405 Example 5 (1-ethyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one)::US10428063, Example 5 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 35.1 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415405 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415405&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 134177545 433915442 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829168 CC(C)(C)OC(=O)N1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccncc1 InChI=1S/C23H24N4O3/c1-23(2,3)30-22(29)27-14-11-17-18(21(27)28)20(25-16-7-5-4-6-8-16)19(26-17)15-9-12-24-13-10-15/h4-10,12-13,25-26H,11,14H2,1-3H3 GJVRUUHMZUPZBQ-UHFFFAOYSA-N 415406 Intermediate 1-1-3::US10428063, Example 6 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 10.9 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415406&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442131 433915443 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829169 Fc1ccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2)cc1 InChI=1S/C18H15FN4O/c19-12-1-3-13(4-2-12)22-17-15-14(7-10-21-18(15)24)23-16(17)11-5-8-20-9-6-11/h1-6,8-9,22-23H,7,10H2,(H,21,24) NUEWYTRRGILZOK-UHFFFAOYSA-N 415407 Intermediate 1-1-4::US10428063, Example 7 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 19.8 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415407&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442121 433915444 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829170 Nc1cc(CNC2=C(C(=S)Nc3ccccc3)C(=O)NCC2)ccn1 InChI=1S/C18H19N5OS/c19-15-10-12(6-8-20-15)11-22-14-7-9-21-17(24)16(14)18(25)23-13-4-2-1-3-5-13/h1-6,8,10,22H,7,9,11H2,(H2,19,20)(H,21,24)(H,23,25) LGOMNQHSEWHCEE-UHFFFAOYSA-N 415408 Intermediate 1-2-6::US10428063, Example 8 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 138 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415408 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415408&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122452985 433915445 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829171 COCCn1c2CCNC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C21H22N4O2/c1-27-14-13-25-17-9-12-23-21(26)18(17)19(24-16-5-3-2-4-6-16)20(25)15-7-10-22-11-8-15/h2-8,10-11,24H,9,12-14H2,1H3,(H,23,26) GEKFWIIAEBLLDI-UHFFFAOYSA-N 415409 Example 9 (1-(2-methoxyethyl)-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one)::US10428063, Example 9 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 354 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415409&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122452986 433915446 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829172 CC(C)C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C(=O)C(C)C)C(=O)c2c1Nc1ccccc1 InChI=1S/C26H29N5O3/c1-15(2)24(32)30-20-14-17(10-12-27-20)22-23(28-18-8-6-5-7-9-18)21-19(29-22)11-13-31(26(21)34)25(33)16(3)4/h5-10,12,14-16,28-29H,11,13H2,1-4H3,(H,27,30,32) QABRGAPDSSWJHB-UHFFFAOYSA-N 415410 (2-methyl-N-{4-[5-(2-methylpropanoyl)-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide)::US10428063, Example 10 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 319 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415410&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442114 433915447 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829173 CCn1c2CCNC(=O)c2c(Nc2ccc(F)cc2)c1-c1ccncc1 InChI=1S/C20H19FN4O/c1-2-25-16-9-12-23-20(26)17(16)18(19(25)13-7-10-22-11-8-13)24-15-5-3-14(21)4-6-15/h3-8,10-11,24H,2,9,12H2,1H3,(H,23,26) ZFBPEJIHPQLPQW-UHFFFAOYSA-N 415411 Example 11 (1-ethyl-3-[(4-fluorophenyl)amino]-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one)::US10428063, Example 11 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 64.5 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415411&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442124 433915448 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829174 Cc1cc(ccn1)-c1[nH]c2CCNC(=O)c2c1Nc1ccccc1 InChI=1S/C19H18N4O/c1-12-11-13(7-9-20-12)17-18(22-14-5-3-2-4-6-14)16-15(23-17)8-10-21-19(16)24/h2-7,9,11,22-23H,8,10H2,1H3,(H,21,24) CIPZCIODYGUAJE-UHFFFAOYSA-N 415412 Intermediate 1-2-7::US10428063, Example 12 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 15.4 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415412&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442116 433915449 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829175 CCn1c2CCNC(=O)c2c(Nc2ccccc2)c1-c1ccnc(C)c1 InChI=1S/C21H22N4O/c1-3-25-17-10-12-23-21(26)18(17)19(24-16-7-5-4-6-8-16)20(25)15-9-11-22-14(2)13-15/h4-9,11,13,24H,3,10,12H2,1-2H3,(H,23,26) QKCJUUSNQHZWRN-UHFFFAOYSA-N 415413 Example 13 (1-ethyl-2-(2-methylpyridin-4-yl)-3-(phenylamino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one)::US10428063, Example 13 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 972 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415413 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415413&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442092 433915450 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829176 CC(=O)Nc1cc(ccn1)-c1[nH]c2CCNC(=O)c2c1Nc1ccccc1 InChI=1S/C20H19N5O2/c1-12(26)23-16-11-13(7-9-21-16)18-19(24-14-5-3-2-4-6-14)17-15(25-18)8-10-22-20(17)27/h2-7,9,11,24-25H,8,10H2,1H3,(H,22,27)(H,21,23,26) OEXTZXWPZXNIIH-UHFFFAOYSA-N 415414 Example 14 (N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide)::US10428063, Example 14 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 18.3 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415414&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442118 433915451 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829177 CCn1c2CCNC(=O)c2c(Nc2ccccc2)c1-c1ccnc(NC(C)=O)c1 InChI=1S/C22H23N5O2/c1-3-27-17-10-12-24-22(29)19(17)20(26-16-7-5-4-6-8-16)21(27)15-9-11-23-18(13-15)25-14(2)28/h4-9,11,13,26H,3,10,12H2,1-2H3,(H,24,29)(H,23,25,28) GWHJCBCVDQYPEH-UHFFFAOYSA-N 415415 Example 15 (N-{4-[1-ethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide)::US10428063, Example 15 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 79.0 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415415 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415415&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122452998 433915452 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829178 Fc1cnccc1CNC1=C(C(=S)Nc2ccccc2)C(=O)NCC1 InChI=1S/C18H17FN4OS/c19-14-11-20-8-6-12(14)10-22-15-7-9-21-17(24)16(15)18(25)23-13-4-2-1-3-5-13/h1-6,8,11,22H,7,9-10H2,(H,21,24)(H,23,25) SLNSIQYOXJGWPI-UHFFFAOYSA-N 415416 Intermediate 1-2-8::US10428063, Example 16 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 19.1 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415416&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122452987 433915453 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829179 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccncc1F InChI=1S/C19H17FN4O/c1-24-10-8-15-16(19(24)25)18(22-12-5-3-2-4-6-12)17(23-15)13-7-9-21-11-14(13)20/h2-7,9,11,22-23H,8,10H2,1H3 DBYNGCLZHACOAD-UHFFFAOYSA-N 415417 Intermediate 1-2-9::US10428063, Example 17 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 8.70 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415417 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415417&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442110 433915454 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829180 Fc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1ccccc1 InChI=1S/C18H15FN4O/c19-13-10-20-8-6-12(13)16-17(22-11-4-2-1-3-5-11)15-14(23-16)7-9-21-18(15)24/h1-6,8,10,22-23H,7,9H2,(H,21,24) OMZKWGHPTPHNLI-UHFFFAOYSA-N 415418 Example 18 (2-(3-fluoropyridin-4-yl)-3-(phenylamino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one)::US10428063, Example 18 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 11.5 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415418&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122452996 433915455 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829181 CCNC(=O)Nc1cc(ccn1)-c1[nH]c2CCNC(=O)c2c1Nc1ccccc1 InChI=1S/C21H22N6O2/c1-2-22-21(29)27-16-12-13(8-10-23-16)18-19(25-14-6-4-3-5-7-14)17-15(26-18)9-11-24-20(17)28/h3-8,10,12,25-26H,2,9,11H2,1H3,(H,24,28)(H2,22,23,27,29) DHGHCMGLJSBXFY-UHFFFAOYSA-N 415419 Example 19 (1-ethyl-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}urea)::US10428063, Example 19 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 19.5 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415419&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442117 433915456 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829182 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccncc1 InChI=1S/C19H18N4O/c1-23-12-9-15-16(19(23)24)18(21-14-5-3-2-4-6-14)17(22-15)13-7-10-20-11-8-13/h2-8,10-11,21-22H,9,12H2,1H3 UVSUXLDMQZJPLM-UHFFFAOYSA-N 415420 Intermediate 1-1-5::US10428063, Example 20 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 13.4 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415420&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442109 433915457 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829183 CN1CCC(NCc2ccnc(N)c2)=C(C(=S)Nc2ccccc2)C1=O InChI=1S/C19H21N5OS/c1-24-10-8-15(22-12-13-7-9-21-16(20)11-13)17(19(24)25)18(26)23-14-5-3-2-4-6-14/h2-7,9,11,22H,8,10,12H2,1H3,(H2,20,21)(H,23,26) CKYNKJMNJPWAJU-UHFFFAOYSA-N 415421 Intermediate 1-2-11::US10428063, Example 21 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 170 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415421&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122452990 433915458 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829184 COc1cnccc1-c1[nH]c2CCN(C)C(=O)c2c1Nc1ccccc1 InChI=1S/C20H20N4O2/c1-24-11-9-15-17(20(24)25)19(22-13-6-4-3-5-7-13)18(23-15)14-8-10-21-12-16(14)26-2/h3-8,10,12,22-23H,9,11H2,1-2H3 KAFZCESMDVJHDJ-UHFFFAOYSA-N 415422 2-(3-methoxypyridin-4-yl)-5-methyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 22 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 26.9 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415422 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415422&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442119 433915459 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829185 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(C)=O)c1 InChI=1S/C21H21N5O2/c1-13(27)23-17-12-14(8-10-22-17)19-20(24-15-6-4-3-5-7-15)18-16(25-19)9-11-26(2)21(18)28/h3-8,10,12,24-25H,9,11H2,1-2H3,(H,22,23,27) LPYBJNPKBPALQQ-UHFFFAOYSA-N 415423 N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide::US10428063, Example 23 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 23.2 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415423 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415423&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122452966 433915460 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829186 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(=O)C2CC2)c1 InChI=1S/C23H23N5O2/c1-28-12-10-17-19(23(28)30)21(25-16-5-3-2-4-6-16)20(26-17)15-9-11-24-18(13-15)27-22(29)14-7-8-14/h2-6,9,11,13-14,25-26H,7-8,10,12H2,1H3,(H,24,27,29) CAOVBAQHBWKZJG-UHFFFAOYSA-N 415424 N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428063, Example 24 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 15.3 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415424 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415424&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442100 433915461 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829187 CN5CCc4[nH]c(c2ccnc(NC(=O)[C@H]1C[C@H]1F)c2)c(Nc3ccccc3)c4C5=O InChI=1S/C23H22FN5O2/c1-29-10-8-17-19(23(29)31)21(26-14-5-3-2-4-6-14)20(27-17)13-7-9-25-18(11-13)28-22(30)15-12-16(15)24/h2-7,9,11,15-16,26-27H,8,10,12H2,1H3,(H,25,28,30) BSAVGANXIAKUQK-UHFFFAOYSA-N 415425 US10428063, Example 25::US10428063, Example 40::rel-(1R,2R)-2-fluoro-N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO 2016/120196, Example 40::US20230322767, Example No. 40 WO 2016/120196::US20230339939, WO 2016/120196, Example 40 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Homo sapiens 17.1 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415425 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415425&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442136 433915462 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829188 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccncc1OCCO InChI=1S/C21H22N4O3/c1-25-10-8-16-18(21(25)27)20(23-14-5-3-2-4-6-14)19(24-16)15-7-9-22-13-17(15)28-12-11-26/h2-7,9,13,23-24,26H,8,10-12H2,1H3 WTPJLESASIDJJN-UHFFFAOYSA-N 415426 2-[3-(2-hydroxyethoxy)pyridin-4-yl]-5-methyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 26 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 47.6 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415426 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415426&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442128 433915463 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829189 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccncc1OCC1CC1 InChI=1S/C23H24N4O2/c1-27-12-10-18-20(23(27)28)22(25-16-5-3-2-4-6-16)21(26-18)17-9-11-24-13-19(17)29-14-15-7-8-15/h2-6,9,11,13,15,25-26H,7-8,10,12,14H2,1H3 DWJYBDDLRDYXNW-UHFFFAOYSA-N 415427 2-[3-(cyclopropylmethoxy)pyridin-4-yl]-5-methyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 27 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 21.7 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415427 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415427&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442133 433915464 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829190 CCCOc1cnccc1-c1[nH]c2CCN(C)C(=O)c2c1Nc1ccccc1 InChI=1S/C22H24N4O2/c1-3-13-28-18-14-23-11-9-16(18)20-21(24-15-7-5-4-6-8-15)19-17(25-20)10-12-26(2)22(19)27/h4-9,11,14,24-25H,3,10,12-13H2,1-2H3 HZPXRJQBQGCGHX-UHFFFAOYSA-N 415428 5-methyl-3-(phenylamino)-2-(3-propoxypyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 28 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 51.6 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415428 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415428&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442113 433915465 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829191 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccncc1OCC(F)F InChI=1S/C21H20F2N4O2/c1-27-10-8-15-18(21(27)28)20(25-13-5-3-2-4-6-13)19(26-15)14-7-9-24-11-16(14)29-12-17(22)23/h2-7,9,11,17,25-26H,8,10,12H2,1H3 HUALIAMKWGJQLP-UHFFFAOYSA-N 415429 2-[3-(2,2-difluoroethoxy)pyridin-4-yl]-5-methyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 29 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 70.8 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415429 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415429&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122452976 433915466 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829192 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccncc1OCC(F)(F)F InChI=1S/C21H19F3N4O2/c1-28-10-8-15-17(20(28)29)19(26-13-5-3-2-4-6-13)18(27-15)14-7-9-25-11-16(14)30-12-21(22,23)24/h2-7,9,11,26-27H,8,10,12H2,1H3 UMBUKOUDYYBRIL-UHFFFAOYSA-N 415430 5-methyl-3-(phenylamino)-2-[3-(2,2,2-trifluoroethoxy)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 30 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 84.3 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415430 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415430&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442112 433915467 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829193 COCCOc1cnccc1-c1[nH]c2CCN(C)C(=O)c2c1Nc1ccccc1 InChI=1S/C22H24N4O3/c1-26-11-9-17-19(22(26)27)21(24-15-6-4-3-5-7-15)20(25-17)16-8-10-23-14-18(16)29-13-12-28-2/h3-8,10,14,24-25H,9,11-13H2,1-2H3 SBAJHPJHUACWCB-UHFFFAOYSA-N 415431 2-[3-(2-methoxyethoxy)pyridin-4-yl]-5-methyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 31 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 9.93 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415431 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415431&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442096 433915468 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829194 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccncc1OCc1ccccc1 InChI=1S/C26H24N4O2/c1-30-15-13-21-23(26(30)31)25(28-19-10-6-3-7-11-19)24(29-21)20-12-14-27-16-22(20)32-17-18-8-4-2-5-9-18/h2-12,14,16,28-29H,13,15,17H2,1H3 LKDBYXFAZLMYQU-UHFFFAOYSA-N 415432 2-[3-(benzyloxy)pyridin-4-yl]-5-methyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 32 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 41.6 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415432&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442108 433915469 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829195 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccncc1OCCC(F)(F)F InChI=1S/C22H21F3N4O2/c1-29-11-8-16-18(21(29)30)20(27-14-5-3-2-4-6-14)19(28-16)15-7-10-26-13-17(15)31-12-9-22(23,24)25/h2-7,10,13,27-28H,8-9,11-12H2,1H3 VBXMQIJCTIBQGT-UHFFFAOYSA-N 415433 5-methyl-3-(phenylamino)-2-[3-(3,3,3-trifluoropropoxy)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 33 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 51.8 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415433 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415433&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442126 433915470 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829196 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccncc1OCC1CCOC1 415434 5-methyl-3-(phenylamino)-2-{3-[(3S)-tetrahydrofuran-3-ylmethoxy]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 34 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 22.5 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415434&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122453002 433915471 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829197 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccncc1OCCC(C)(C)C InChI=1S/C25H30N4O2/c1-25(2,3)12-15-31-20-16-26-13-10-18(20)22-23(27-17-8-6-5-7-9-17)21-19(28-22)11-14-29(4)24(21)30/h5-10,13,16,27-28H,11-12,14-15H2,1-4H3 GVYRCVRGMLMKJR-UHFFFAOYSA-N 415435 2-[3-(3,3-dimethylbutoxy)pyridin-4-yl]-5-methyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 35 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 85.9 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415435&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122452969 433915472 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829198 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc2[nH]cnc12 InChI=1S/C20H18N6O/c1-26-10-8-14-15(20(26)27)18(24-12-5-3-2-4-6-12)16(25-14)13-7-9-21-19-17(13)22-11-23-19/h2-7,9,11,24-25H,8,10H2,1H3,(H,21,22,23) ZAAJFKNLSCKBCT-UHFFFAOYSA-N 415436 2-(3H-imidazo[4,5-b]pyridin-7-yl)-5-methyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 36 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 34.8 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415436&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442105 433915473 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829199 Fc1ccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CC2)cc1F InChI=1S/C22H20F2N4O2/c23-15-4-3-13(9-16(15)24)27-21-19-17(6-8-26-22(19)29)28-20(21)14-5-7-25-10-18(14)30-11-12-1-2-12/h3-5,7,9-10,12,27-28H,1-2,6,8,11H2,(H,26,29) PCLNHYMAAWZNGJ-UHFFFAOYSA-N 415437 2-[3-(cyclopropylmethoxy)pyridin-4-yl]-3-[(3,4-difluorophenyl)amino]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 37 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 59.8 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415437&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442099 433915474 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829200 Fc1ccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CC2)cc1 InChI=1S/C22H21FN4O2/c23-14-3-5-15(6-4-14)26-21-19-17(8-10-25-22(19)28)27-20(21)16-7-9-24-11-18(16)29-12-13-1-2-13/h3-7,9,11,13,26-27H,1-2,8,10,12H2,(H,25,28) QXHSDGITOUSOJT-UHFFFAOYSA-N 415438 2-[3-(cyclopropylmethoxy)pyridin-4-yl]-3-[(4-fluorophenyl)amino]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 38 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 56.1 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415438 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415438&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442127 433915475 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829201 Fc1cccc(Nc2c([nH]c3CCNC(=O)c23)-c2ccncc2OCC2CC2)c1 InChI=1S/C22H21FN4O2/c23-14-2-1-3-15(10-14)26-21-19-17(7-9-25-22(19)28)27-20(21)16-6-8-24-11-18(16)29-12-13-4-5-13/h1-3,6,8,10-11,13,26-27H,4-5,7,9,12H2,(H,25,28) KHNSDFACFKOTPQ-UHFFFAOYSA-N 415439 2-[3-(cyclopropylmethoxy)pyridin-4-yl]-3-[(3-fluorophenyl)amino]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 39 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 24.1 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415439&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442135 433915476 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829202 CN5CCc4[nH]c(c2ccnc(NC(=O)[C@H]1C[C@H]1F)c2)c(Nc3ccccc3)c4C5=O InChI=1S/C23H22FN5O2/c1-29-10-8-17-19(23(29)31)21(26-14-5-3-2-4-6-14)20(27-17)13-7-9-25-18(11-13)28-22(30)15-12-16(15)24/h2-7,9,11,15-16,26-27H,8,10,12H2,1H3,(H,25,28,30) BSAVGANXIAKUQK-UHFFFAOYSA-N 415425 US10428063, Example 25::US10428063, Example 40::rel-(1R,2R)-2-fluoro-N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO 2016/120196, Example 40::US20230322767, Example No. 40 WO 2016/120196::US20230339939, WO 2016/120196, Example 40 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Homo sapiens 28.1 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415425 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415425&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442136 433915462 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829203 FC(F)COc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1cccc(F)c1 InChI=1S/C20H17F3N4O2/c21-11-2-1-3-12(8-11)26-19-17-14(5-7-25-20(17)28)27-18(19)13-4-6-24-9-15(13)29-10-16(22)23/h1-4,6,8-9,16,26-27H,5,7,10H2,(H,25,28) BLLDXXIYTCRJCV-UHFFFAOYSA-N 415441 2-[3-(2,2-difluoroethoxy)pyridin-4-yl]-3-[(3-fluorophenyl)amino]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 41 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 36.8 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415441&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442120 433915477 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829204 FC(F)COc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1ccc(F)cc1 InChI=1S/C20H17F3N4O2/c21-11-1-3-12(4-2-11)26-19-17-14(6-8-25-20(17)28)27-18(19)13-5-7-24-9-15(13)29-10-16(22)23/h1-5,7,9,16,26-27H,6,8,10H2,(H,25,28) ATEAQDVTGZGZBZ-UHFFFAOYSA-N 415442 2-[3-(2,2-difluoroethoxy)pyridin-4-yl]-3-[(4-fluorophenyl)amino]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 42 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 111 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415442 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415442&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442123 433915478 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829205 FC(F)COc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1ccc(F)c(F)c1 InChI=1S/C20H16F4N4O2/c21-12-2-1-10(7-13(12)22)27-19-17-14(4-6-26-20(17)29)28-18(19)11-3-5-25-8-15(11)30-9-16(23)24/h1-3,5,7-8,16,27-28H,4,6,9H2,(H,26,29) REFFKXXXDGIFIG-UHFFFAOYSA-N 415443 2-[3-(2,2-difluoroethoxy)pyridin-4-yl]-3-[(3,4-difluorophenyl)amino]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 43 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 136 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415443&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442102 433915479 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829206 CN(C)CCOc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1ccc(F)c(F)c1 InChI=1S/C22H23F2N5O2/c1-29(2)9-10-31-18-12-25-7-5-14(18)20-21(19-17(28-20)6-8-26-22(19)30)27-13-3-4-15(23)16(24)11-13/h3-5,7,11-12,27-28H,6,8-10H2,1-2H3,(H,26,30) JJZRXYNODCGYIZ-UHFFFAOYSA-N 415444 2-{3-[2-(dimethylamino)ethoxy]pyridin-4-yl}-3-[(4-fluorophenyl)amino]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 44 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 69.9 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415444 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415444&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122452971 433915480 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829207 COCCOc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1ccc(F)c(F)c1 InChI=1S/C21H20F2N4O3/c1-29-8-9-30-17-11-24-6-4-13(17)19-20(18-16(27-19)5-7-25-21(18)28)26-12-2-3-14(22)15(23)10-12/h2-4,6,10-11,26-27H,5,7-9H2,1H3,(H,25,28) WTGWYNSJAFEUEL-UHFFFAOYSA-N 415445 3-[(3,4-difluorophenyl)amino]-2-[3-(2-methoxyethoxy)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 45 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 28.0 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415445 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415445&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442106 433915481 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829208 COCCOc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1ccc(F)cc1 InChI=1S/C21H21FN4O3/c1-28-10-11-29-17-12-23-8-6-15(17)19-20(25-14-4-2-13(22)3-5-14)18-16(26-19)7-9-24-21(18)27/h2-6,8,12,25-26H,7,9-11H2,1H3,(H,24,27) DHMKBMQJCRVLDO-UHFFFAOYSA-N 415446 3-[(4-fluorophenyl)amino]-2-[3-(2-methoxyethoxy)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 46 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 32.8 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415446&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442132 433915482 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829209 COCCOc1cnccc1-c1[nH]c2CCNC(=O)c2c1Nc1cccc(F)c1 InChI=1S/C21H21FN4O3/c1-28-9-10-29-17-12-23-7-5-15(17)19-20(25-14-4-2-3-13(22)11-14)18-16(26-19)6-8-24-21(18)27/h2-5,7,11-12,25-26H,6,8-10H2,1H3,(H,24,27) JTNQRYYGVCULTJ-UHFFFAOYSA-N 415447 3-[(3-fluorophenyl)amino]-2-[3-(2-methoxyethoxy)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one::US10428063, Example 47 Mitotic checkpoint serine/threonine-protein kinase BUB1 [704-1085] Human 19.4 US Patent 10.7270/Q2KP84JN aid1803872 US10428063 Graham, K; Klar, U; Briem, H; Schulze, V; Siemeister, G; Lienau, P; Tempel, R; Balint, J 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415447 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=331&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415447&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1+%5B704-1085%5D&column=ki&startPg=0&Increment=50&submit=Search 122442101 433915483 1 DAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4